Advocates say the price is a step in the right direction. But does it go far enough?
Questions and answers on potential risk of neural tube defects in infants born to women who were taking dolutegravir (DTG) at the time of conception.
Tivicay is a mainstay of HIV treatment and the focus of simplified treatment studies due to its power and high drug resistance barrier; however, side effects concerns have recently been raised.
Stribild, a once-daily, single-pill regimen, and Tivicay, a recently approved integrase inhibitor, are now officially on the list of "preferred" HIV medications in official U.S. HIV treatment guidelines.